Acuta Capital Partners, LLC Celldex Therapeutics, Inc. Transaction History

Acuta Capital Partners, LLC

$122 Million
Q1 2024

A detailed history of Acuta Capital Partners, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 109,000 shares of CLDX stock, worth $4.03 Million. This represents 3.74% of its overall portfolio holdings.

Number of Shares

109,000

Previous 69,400 57.06%

Holding current value

$4.03 Million

Previous $2.75 Million 66.21%

% of portfolio

3.74%

Previous 2.14%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$35.22 - $51.88 $1.39 Million - $2.05 Million	39,600 Added 57.06%	109,000 $4.57 Million
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $1.2 Million - $2.15 Million	-52,941 Reduced 43.27%	69,400 $2.75 Million
Q3 2023 Nov 14, 2023	SELL	$25.45 - $37.46 $50 - $74	-2 Reduced -0.0%	122,341 $3.37 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $25,534 - $32,270	843 Added 0.69%	122,343 $4.15 Million
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $226,070 - $308,295	6,500 Added 5.65%	121,500 $4.37 Million

Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $4.23 Million - $6.91 Million	-152,195 Reduced 56.96%	115,000 $5.13 Million
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $1.14 Million - $2.08 Million	-55,703 Reduced 17.25%	267,195 $7.2 Million
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $475,408 - $676,304	-17,200 Reduced 5.06%	322,898 $11 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $92,696 - $146,189	2,598 Added 0.77%	340,098 $13.1 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $18.8 Million - $36.4 Million	-649,906 Reduced 65.82%	337,500 $18.2 Million
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $623,743 - $1.07 Million	-30,118 Reduced 2.96%	987,406 $33 Million
Q1 2021 May 17, 2021	SELL	$16.19 - $29.91 $9.88 Million - $18.2 Million	-609,976 Reduced 37.48%	1,017,524 $21 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $1.24 Million - $1.88 Million	82,500 Added 5.34%	1,627,500 $28.5 Million
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $5.26 Million - $8.28 Million	545,000 Added 54.5%	1,545,000 $22.9 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $1.61 Million - $13.4 Million	1,000,000 New	1,000,000 $13 Million

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

61.2M

Call Options Held

291K

Put Options Held

246K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.73B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Account

Acuta Capital Partners, LLC Celldex Therapeutics, Inc. Transaction History